Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 561.50
0.00 (0.00%)
Last updated: Oct 6, 2025, 9:30 AM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 130.93 billion as of October 7, 2025. Its market cap has increased by 229.72% in one year.
Market Cap
130.93B
Enterprise Value
126.13B
Revenue
1.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
561.50
Market Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 130.93B, an increase of 870.65%. That is a compound annual growth rate of 175.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 130.93B | 252.80% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 294.55B |
| Hansoh Pharmaceutical Group Company | 234.53B |
| JD Health International | 207.30B |
| Innovent Biologics | 172.13B |
| WuXi Biologics | 170.68B |
| Sino Biopharmaceutical | 148.38B |
| Akeso | 130.16B |
| CSPC Pharmaceutical Group | 110.90B |